Haley Dion serves as the Executive Director at United Against Inequities in Disease since July 2022, focusing on the organization's strategic growth and oversight of a leadership board supporting health equity initiatives. Previously, Haley held various roles within UAID, including National Board Director of Community Projects and National Board Intern, demonstrating a strong commitment to community health and partnerships. Currently a Research Technician at the Ragon Institute, Haley contributes to research on vaginal microbiota and preterm birth. Past experience includes managing an educational HPV intervention study at the Duke Global Health Institute and participating in numerous research roles at Duke University and McLean Hospital. Haley holds a Bachelor of Arts in International Comparative Studies from Duke University and has a background as a NCAA Division I student athlete.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.